News from the Lab: What if we could slow down ALS?
Published on 21/06/2026
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease that progressively destroys the neurons responsible for movement. As it advances, patients gradually lose their ability to move, speak, eat and even breathe.
There’s currently no cure and the available treatments only manage to slow the progression of the disease slightly. Developing new therapies is therefore one of the major challenges facing biomedical research today.
With this aim in mind, the team led by Ana Martínez and Carmen Gil at CSIC’s Margarita Salas Biological Research Centre has spent years studying TDP-43, a protein that’s altered in over 97% of ALS patients and is closely linked to the disease’s progression.



